SlideShare a Scribd company logo
1 of 11
Download to read offline
Interim Report
1 January – 30 June 2012
Q2 2012
Macro update

 Global economy and private consumption to slow in 2012
     Debt crisis in parts of Western Europe has a negative impact
     Emerging markets shows relatively good growth
 Hygiene products
     Good growth in Emerging markets
     Low or no growth in Western Europe and North America
 Forest products
     Lower European demand and unacceptably low prices
      in publication paper
     Continued weak demand and unsatisfactory low prices
      in solid-wood products
     Price increases for Kraftliner during Q2



2                                                                    Interim Report Q2 2012
Q2 2012
Closed five important deals

 Acquisition of Georgia-Pacific’s European tissue operations
 Acquisition of Everbeauty an Asian hygiene products
  company
 Increased shareholding in Vinda
 Acquisition of PISA in Chile
 Divestment of the Packaging business, excluding the two
  kraftliner mills




3                                                  Interim Report Q2 2012
Summary
Q2 2012 vs Q2 2011

 Sales increased 2%*
        Hygiene business
                Higher volumes
                Higher prices
                Good growth in emerging markets
                       •    Personal Care, 20%**
                       •    Tissue, 17%**
        Forest Products
                Lower volumes
                Lower prices
 EBIT increased 16%***
        Higher volumes
        Lower raw material and energy costs



* Excluding exchange rate movements and divestment
** Excluding exchange rate movements
*** Excluding items affecting comparability , exchange rate movements and divestments
4                                                                                       Interim Report Q2 2012
Q2 2012 results
SEK millions                                               Q2       Q2    Change, Change,
    unless otherwise stated                              2012     2011      %      %**
Net sales                                               20,273   20,415     -1      2
EBIT*                                                    2,105    1,810     16     16
EBIT margin* (%)                                          10.4      8.9
Profit before tax*                                       1,789    1,527     17
Earnings per share (SEK)                                  1.85     1.96
Operating cash flow                                      2,391    1,868
Debt/Equity ratio                                         0.41     0.55




* Excluding items affecting comparability
** Excluding exchange rate movements, and divestments

5                                                                                       Interim Report Q2 2012
Q2 2012 vs. Q1 2012
Summary

 Group
        Sales increased 4%
        EBIT increased 15%*

 Business areas
        Personal Care, EBIT increased 17%*
                • Higher volumes
                • Improved product mix
        Tissue, EBIT increased 10%*
                • Higher volumes
                • Lower energy costs
                • Higher raw material costs
        Forest Products, EBIT increased 31%*
                • Higher prices
                • Lower volumes
                • Lower raw material and energy costs

* Excluding items affecting comparability

6                                                       Interim Report Q2 2012
Personal Care
Q2 2012 vs. Q2 2011

                         6,530
                                                          Sales increased 7% (+10%*)
                                 6,116
                                                            Incontinence care increased 9%*
                          7%
                                                             Baby diapers increased 14%*
                                                             Feminine care increased 8%*
                                                             Emerging markets increased 20%**
SALES SEKm              Q212     Q211


                          781
                                                          EBIT increased 34%*** (41%****)
                         34%*** 582
                                                             Higher volumes
                                                             Improved product mix
                                                             Cost savings
                                                             Lower raw material costs
EBIT*** SEKm            Q212     Q211

EBIT margin***          12.0% 9.5%

*     Excluding exchange rate movements and divestments
**    Excluding exchange rate movements
*** Excluding items affecting comparability
**** Excluding items affecting comparability, exchange rate movements and divestments
7                                                                                           Interim Report Q2 2012
Tissue
Q2 2012 vs. Q2 2011

                        9,461    9,609
                                                          Sales decreased 2% (+4%*)
                                                             Consumer tissue increased 5%*
                         -2%
                                                             AFH tissue increased 2%*
                                                             Emerging markets increased 17%**

                                                          EBIT increased by 53%*** (45%****)
SALES SEKm              Q212     Q211
                                                             Higher prices
                         1,021                               Improved product mix
                                                             Lower raw material costs
                         53%     668
                                                             Cost savings


EBIT*** SEKm            Q212     Q211

EBIT margin***          10.8% 7.0%

*     Excluding exchange rate movements and divestments
**    Excluding exchange rate movements
*** Excluding items affecting comparability
**** Excluding items affecting comparability and exchange rate movements
 8                                                                                       Interim Report Q2 2012
Forest Products
Q2 2012 vs. Q2 2011

                                               Sales decreased 9%
                           4,868
                                   5,322        Publication papers, decreased sales
                                                 • Lower volumes
                            -9%
                                                Solid-wood products, flat sales
                                                 • Higher volumes
                                                 • Lower prices
SALES SEKm                Q212     Q211         Kraftliner, decreased sales
                                                 • Lower prices
                                                 • Higher volumes

                                    659
                                                Pulp, decreased sales
                            433
                                                 • Lower prices and volumes
                          -34%*
                                               EBIT decreased 34%*
EBIT* SEKm                Q212     Q211         Lower prices
EBIT margin*               8.9%     12.4%
                                                Higher raw material costs


*   Excluding items affecting comparability

9                                                                                  Interim Report Q2 2012
Q&A



10         Interim Report Q2 2012
SCA interim report Q2 2012

More Related Content

Viewers also liked

SCA delivers binding offer to acquire Georgia-Pacific´s European tissue opera...
SCA delivers binding offer to acquire Georgia-Pacific´s European tissue opera...SCA delivers binding offer to acquire Georgia-Pacific´s European tissue opera...
SCA delivers binding offer to acquire Georgia-Pacific´s European tissue opera...SCA Svenska Cellulosa Aktiebolaget
 
SCA's Presentation at the Cheuvreux Pan Europe Forum 22 May 2012
SCA's Presentation at the Cheuvreux Pan Europe Forum 22 May 2012SCA's Presentation at the Cheuvreux Pan Europe Forum 22 May 2012
SCA's Presentation at the Cheuvreux Pan Europe Forum 22 May 2012SCA Svenska Cellulosa Aktiebolaget
 
SCA CFO Lennart Persson presentation at SEB TMC seminar September 22 2011
SCA CFO Lennart Persson presentation at SEB TMC seminar September 22 2011SCA CFO Lennart Persson presentation at SEB TMC seminar September 22 2011
SCA CFO Lennart Persson presentation at SEB TMC seminar September 22 2011SCA Svenska Cellulosa Aktiebolaget
 
SCA Presentation at the Handelsbanken Materials and Energy Seminar
SCA Presentation at the Handelsbanken Materials and Energy SeminarSCA Presentation at the Handelsbanken Materials and Energy Seminar
SCA Presentation at the Handelsbanken Materials and Energy SeminarSCA Svenska Cellulosa Aktiebolaget
 

Viewers also liked (20)

SCA's presentation from the ABG Consumer Seminar in Stockholm
SCA's presentation from the ABG Consumer Seminar in StockholmSCA's presentation from the ABG Consumer Seminar in Stockholm
SCA's presentation from the ABG Consumer Seminar in Stockholm
 
SCAs Annual General Meeting 2012
SCAs Annual General Meeting 2012SCAs Annual General Meeting 2012
SCAs Annual General Meeting 2012
 
SCA interim report Q1 2011
SCA interim report Q1 2011SCA interim report Q1 2011
SCA interim report Q1 2011
 
SCA delivers binding offer to acquire Georgia-Pacific´s European tissue opera...
SCA delivers binding offer to acquire Georgia-Pacific´s European tissue opera...SCA delivers binding offer to acquire Georgia-Pacific´s European tissue opera...
SCA delivers binding offer to acquire Georgia-Pacific´s European tissue opera...
 
SCA presentation at Cheuvreux Pan Europe Forum 2011
SCA presentation at Cheuvreux Pan Europe Forum 2011SCA presentation at Cheuvreux Pan Europe Forum 2011
SCA presentation at Cheuvreux Pan Europe Forum 2011
 
SCA's Presentation at the Cheuvreux Pan Europe Forum 22 May 2012
SCA's Presentation at the Cheuvreux Pan Europe Forum 22 May 2012SCA's Presentation at the Cheuvreux Pan Europe Forum 22 May 2012
SCA's Presentation at the Cheuvreux Pan Europe Forum 22 May 2012
 
SCAs Presentation Q1 2015
SCAs Presentation Q1 2015SCAs Presentation Q1 2015
SCAs Presentation Q1 2015
 
SCA's presentation at SEB Enskilda TMC Seminar
SCA's presentation at SEB Enskilda TMC SeminarSCA's presentation at SEB Enskilda TMC Seminar
SCA's presentation at SEB Enskilda TMC Seminar
 
Deutsche Bank Global Consumer Conference 21 June 2012
Deutsche Bank Global Consumer Conference 21 June 2012Deutsche Bank Global Consumer Conference 21 June 2012
Deutsche Bank Global Consumer Conference 21 June 2012
 
Presentation SCA interim report Q2 2011
Presentation SCA interim report Q2 2011Presentation SCA interim report Q2 2011
Presentation SCA interim report Q2 2011
 
SCA CFO Lennart Persson presentation at SEB TMC seminar September 22 2011
SCA CFO Lennart Persson presentation at SEB TMC seminar September 22 2011SCA CFO Lennart Persson presentation at SEB TMC seminar September 22 2011
SCA CFO Lennart Persson presentation at SEB TMC seminar September 22 2011
 
SCA presentation Cheuvreux Climate Change 6 conference
SCA presentation Cheuvreux Climate Change 6 conferenceSCA presentation Cheuvreux Climate Change 6 conference
SCA presentation Cheuvreux Climate Change 6 conference
 
SCA Presentation at the Handelsbanken Materials and Energy Seminar
SCA Presentation at the Handelsbanken Materials and Energy SeminarSCA Presentation at the Handelsbanken Materials and Energy Seminar
SCA Presentation at the Handelsbanken Materials and Energy Seminar
 
SCA's presentation from Handelsbanken Conference 120910
SCA's presentation from Handelsbanken Conference 120910SCA's presentation from Handelsbanken Conference 120910
SCA's presentation from Handelsbanken Conference 120910
 
SCA Morgan Stanley Consumer Goods, New York
SCA Morgan Stanley Consumer Goods, New YorkSCA Morgan Stanley Consumer Goods, New York
SCA Morgan Stanley Consumer Goods, New York
 
Handelsbanken retail and consumer seminar 2012
Handelsbanken retail and consumer seminar 2012Handelsbanken retail and consumer seminar 2012
Handelsbanken retail and consumer seminar 2012
 
Presentation SCA interim report Q2 2015
Presentation SCA interim report Q2 2015Presentation SCA interim report Q2 2015
Presentation SCA interim report Q2 2015
 
SCA Interim Report Q3 2013
SCA Interim Report Q3 2013SCA Interim Report Q3 2013
SCA Interim Report Q3 2013
 
SCA at UBS Consumer Conference 2014
SCA at UBS Consumer Conference 2014SCA at UBS Consumer Conference 2014
SCA at UBS Consumer Conference 2014
 
SCA Presentation - Interim report for Q1 2013
SCA Presentation - Interim report for Q1 2013SCA Presentation - Interim report for Q1 2013
SCA Presentation - Interim report for Q1 2013
 

Similar to SCA interim report Q2 2012

Q3 2012 Results Investor Presentation
Q3 2012 Results Investor PresentationQ3 2012 Results Investor Presentation
Q3 2012 Results Investor PresentationAkzoNobel
 
AkzoNobel Q2 2012 Investor Presentation
AkzoNobel Q2 2012 Investor PresentationAkzoNobel Q2 2012 Investor Presentation
AkzoNobel Q2 2012 Investor PresentationAkzoNobel
 
Nobia Q1 2012 presentation
Nobia Q1 2012 presentationNobia Q1 2012 presentation
Nobia Q1 2012 presentationNobia Group
 
AkzoNobel Q1 2012 Media Presentation
AkzoNobel Q1 2012 Media PresentationAkzoNobel Q1 2012 Media Presentation
AkzoNobel Q1 2012 Media PresentationAkzoNobel
 
Wessanen Q3 2012 analyst&investors presentation
Wessanen Q3 2012 analyst&investors presentationWessanen Q3 2012 analyst&investors presentation
Wessanen Q3 2012 analyst&investors presentationKlaus Arntz
 
AkzoNobel Q1 2012 Investor Presentation
AkzoNobel Q1 2012 Investor PresentationAkzoNobel Q1 2012 Investor Presentation
AkzoNobel Q1 2012 Investor PresentationAkzoNobel
 
Kemira financial statements bulletin 2012
Kemira financial statements bulletin 2012Kemira financial statements bulletin 2012
Kemira financial statements bulletin 2012Kemira Oyj
 
AkzoNobel Q2 2013 Investor Presentation
AkzoNobel Q2 2013 Investor PresentationAkzoNobel Q2 2013 Investor Presentation
AkzoNobel Q2 2013 Investor PresentationAkzoNobel
 
Q2 2012 Printable Slides
Q2 2012 Printable SlidesQ2 2012 Printable Slides
Q2 2012 Printable SlidesKellogg_Company
 
Axfood q3 2012
Axfood q3 2012Axfood q3 2012
Axfood q3 2012Axfood
 
Fourth Quarter 2011 Masco Earnings Presentation
Fourth Quarter 2011 Masco Earnings PresentationFourth Quarter 2011 Masco Earnings Presentation
Fourth Quarter 2011 Masco Earnings PresentationMasco_Investors
 
Gunnebo Year-End Release 2012
Gunnebo Year-End Release 2012Gunnebo Year-End Release 2012
Gunnebo Year-End Release 2012Gunnebo Group
 
ThomasWeiselTech2007_Handout020707
ThomasWeiselTech2007_Handout020707ThomasWeiselTech2007_Handout020707
ThomasWeiselTech2007_Handout020707finance45
 
Electrolux Interim Report Q2 2012
Electrolux Interim Report Q2 2012Electrolux Interim Report Q2 2012
Electrolux Interim Report Q2 2012Electrolux Group
 
AkzoNobel Q2 2011 Media Presentation
AkzoNobel Q2 2011 Media PresentationAkzoNobel Q2 2011 Media Presentation
AkzoNobel Q2 2011 Media PresentationAkzoNobel
 
Masco Corporation 2012 Fourth Quarter Presentation
Masco Corporation 2012 Fourth Quarter Presentation Masco Corporation 2012 Fourth Quarter Presentation
Masco Corporation 2012 Fourth Quarter Presentation Masco_Investors
 

Similar to SCA interim report Q2 2012 (20)

SCA presentation year-end report Q4 2011
SCA presentation year-end report Q4 2011SCA presentation year-end report Q4 2011
SCA presentation year-end report Q4 2011
 
Q3 2012 Results Investor Presentation
Q3 2012 Results Investor PresentationQ3 2012 Results Investor Presentation
Q3 2012 Results Investor Presentation
 
AkzoNobel Q2 2012 Investor Presentation
AkzoNobel Q2 2012 Investor PresentationAkzoNobel Q2 2012 Investor Presentation
AkzoNobel Q2 2012 Investor Presentation
 
Nobia Q1 2012 presentation
Nobia Q1 2012 presentationNobia Q1 2012 presentation
Nobia Q1 2012 presentation
 
AkzoNobel Q1 2012 Media Presentation
AkzoNobel Q1 2012 Media PresentationAkzoNobel Q1 2012 Media Presentation
AkzoNobel Q1 2012 Media Presentation
 
Wessanen Q3 2012 analyst&investors presentation
Wessanen Q3 2012 analyst&investors presentationWessanen Q3 2012 analyst&investors presentation
Wessanen Q3 2012 analyst&investors presentation
 
Resultados bayer
Resultados bayerResultados bayer
Resultados bayer
 
AkzoNobel Q1 2012 Investor Presentation
AkzoNobel Q1 2012 Investor PresentationAkzoNobel Q1 2012 Investor Presentation
AkzoNobel Q1 2012 Investor Presentation
 
Kemira financial statements bulletin 2012
Kemira financial statements bulletin 2012Kemira financial statements bulletin 2012
Kemira financial statements bulletin 2012
 
AkzoNobel Q2 2013 Investor Presentation
AkzoNobel Q2 2013 Investor PresentationAkzoNobel Q2 2013 Investor Presentation
AkzoNobel Q2 2013 Investor Presentation
 
Q2 2012 Printable Slides
Q2 2012 Printable SlidesQ2 2012 Printable Slides
Q2 2012 Printable Slides
 
Axfood q3 2012
Axfood q3 2012Axfood q3 2012
Axfood q3 2012
 
4Q 2012 Presentation
4Q 2012 Presentation4Q 2012 Presentation
4Q 2012 Presentation
 
Fourth Quarter 2011 Masco Earnings Presentation
Fourth Quarter 2011 Masco Earnings PresentationFourth Quarter 2011 Masco Earnings Presentation
Fourth Quarter 2011 Masco Earnings Presentation
 
Gunnebo Year-End Release 2012
Gunnebo Year-End Release 2012Gunnebo Year-End Release 2012
Gunnebo Year-End Release 2012
 
ThomasWeiselTech2007_Handout020707
ThomasWeiselTech2007_Handout020707ThomasWeiselTech2007_Handout020707
ThomasWeiselTech2007_Handout020707
 
Electrolux Interim Report Q2 2012
Electrolux Interim Report Q2 2012Electrolux Interim Report Q2 2012
Electrolux Interim Report Q2 2012
 
AkzoNobel Q2 2011 Media Presentation
AkzoNobel Q2 2011 Media PresentationAkzoNobel Q2 2011 Media Presentation
AkzoNobel Q2 2011 Media Presentation
 
Masco Corporation 2012 Fourth Quarter Presentation
Masco Corporation 2012 Fourth Quarter Presentation Masco Corporation 2012 Fourth Quarter Presentation
Masco Corporation 2012 Fourth Quarter Presentation
 
Presentation of SCA Year-end report 2010
Presentation of SCA Year-end report 2010Presentation of SCA Year-end report 2010
Presentation of SCA Year-end report 2010
 

More from SCA Svenska Cellulosa Aktiebolaget

SCA's Presentation from the ABGSC SRI conference, June 12 - 2012
SCA's Presentation from the ABGSC SRI conference, June 12 - 2012SCA's Presentation from the ABGSC SRI conference, June 12 - 2012
SCA's Presentation from the ABGSC SRI conference, June 12 - 2012SCA Svenska Cellulosa Aktiebolaget
 
Handelsbanken consumer seminar - SCA presentation by Mats Berencreutz
Handelsbanken consumer seminar - SCA presentation by Mats BerencreutzHandelsbanken consumer seminar - SCA presentation by Mats Berencreutz
Handelsbanken consumer seminar - SCA presentation by Mats BerencreutzSCA Svenska Cellulosa Aktiebolaget
 

More from SCA Svenska Cellulosa Aktiebolaget (14)

SCA Presentation Q2 2016
SCA Presentation Q2 2016SCA Presentation Q2 2016
SCA Presentation Q2 2016
 
SCA Presentation Q1 report 2016
SCA Presentation Q1 report 2016SCA Presentation Q1 report 2016
SCA Presentation Q1 report 2016
 
Presentation SCA Interim Report Q3 2015
Presentation SCA Interim Report Q3 2015Presentation SCA Interim Report Q3 2015
Presentation SCA Interim Report Q3 2015
 
SCA Year-end Report Q4 2014
SCA Year-end Report Q4 2014SCA Year-end Report Q4 2014
SCA Year-end Report Q4 2014
 
Presentation from SCA Interim Report Q2 2014
Presentation from SCA Interim Report Q2 2014Presentation from SCA Interim Report Q2 2014
Presentation from SCA Interim Report Q2 2014
 
SCA Interim Report Q1 2014
SCA Interim Report Q1 2014SCA Interim Report Q1 2014
SCA Interim Report Q1 2014
 
SCA at CAGE Conference 2014
SCA at CAGE Conference 2014SCA at CAGE Conference 2014
SCA at CAGE Conference 2014
 
SCA Year-end Report 2013
SCA Year-end Report 2013SCA Year-end Report 2013
SCA Year-end Report 2013
 
SCA's presentation from UBS European Conference
SCA's presentation from UBS European ConferenceSCA's presentation from UBS European Conference
SCA's presentation from UBS European Conference
 
SCA Capital Market Day 2012
SCA Capital Market Day 2012SCA Capital Market Day 2012
SCA Capital Market Day 2012
 
SCA's Presentation from the ABGSC SRI conference, June 12 - 2012
SCA's Presentation from the ABGSC SRI conference, June 12 - 2012SCA's Presentation from the ABGSC SRI conference, June 12 - 2012
SCA's Presentation from the ABGSC SRI conference, June 12 - 2012
 
SCAs årsstämma 2012
SCAs årsstämma 2012SCAs årsstämma 2012
SCAs årsstämma 2012
 
This is SCA leaflet 2010 / 2011
This is SCA leaflet 2010 / 2011This is SCA leaflet 2010 / 2011
This is SCA leaflet 2010 / 2011
 
Handelsbanken consumer seminar - SCA presentation by Mats Berencreutz
Handelsbanken consumer seminar - SCA presentation by Mats BerencreutzHandelsbanken consumer seminar - SCA presentation by Mats Berencreutz
Handelsbanken consumer seminar - SCA presentation by Mats Berencreutz
 

Recently uploaded

Top^Clinic ^%[+27785538335__Safe*Women's clinic//Abortion Pills In Harare
Top^Clinic ^%[+27785538335__Safe*Women's clinic//Abortion Pills In HarareTop^Clinic ^%[+27785538335__Safe*Women's clinic//Abortion Pills In Harare
Top^Clinic ^%[+27785538335__Safe*Women's clinic//Abortion Pills In Hararedoctorjoe1984
 
How to refresh to be fit for the future world
How to refresh to be fit for the future worldHow to refresh to be fit for the future world
How to refresh to be fit for the future worldChris Skinner
 
The Risks of Ignoring Bookkeeping in Your Business
The Risks of Ignoring Bookkeeping in Your BusinessThe Risks of Ignoring Bookkeeping in Your Business
The Risks of Ignoring Bookkeeping in Your BusinessYourLegal Accounting
 
Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...
Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...
Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...BabaJohn3
 
Global Internal Audit Standards 2024.pdf
Global Internal Audit Standards 2024.pdfGlobal Internal Audit Standards 2024.pdf
Global Internal Audit Standards 2024.pdfAmer Morgan
 
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg PfizerJual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg PfizerPusat Herbal Resmi BPOM
 
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODFRATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODFCaitlinCummins3
 
NFS- Operations Presentation - Recurrent
NFS- Operations Presentation - RecurrentNFS- Operations Presentation - Recurrent
NFS- Operations Presentation - Recurrenttoniquemcintosh1
 
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by AccionSeries A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by AccionAlejandro Cremades
 
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.docGuide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.docssuserf63bd7
 
MichaelStarkes_UncutGemsProjectSummary.pdf
MichaelStarkes_UncutGemsProjectSummary.pdfMichaelStarkes_UncutGemsProjectSummary.pdf
MichaelStarkes_UncutGemsProjectSummary.pdfmstarkes24
 
zidauu _business communication.pptx /pdf
zidauu _business  communication.pptx /pdfzidauu _business  communication.pptx /pdf
zidauu _business communication.pptx /pdfzukhrafshabbir
 
HAL Financial Performance Analysis and Future Prospects
HAL Financial Performance Analysis and Future ProspectsHAL Financial Performance Analysis and Future Prospects
HAL Financial Performance Analysis and Future ProspectsRajesh Gupta
 
Hyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings releaseHyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings releaseirhcs
 
hyundai capital 2023 consolidated financial statements
hyundai capital 2023 consolidated financial statementshyundai capital 2023 consolidated financial statements
hyundai capital 2023 consolidated financial statementsirhcs
 
Exploring-Pipe-Flanges-Applications-Types-and-Benefits.pptx
Exploring-Pipe-Flanges-Applications-Types-and-Benefits.pptxExploring-Pipe-Flanges-Applications-Types-and-Benefits.pptx
Exploring-Pipe-Flanges-Applications-Types-and-Benefits.pptxTexas Flange
 
5 Brilliant Ways To Buy Verified Payoneer Accounts In 2024
5 Brilliant Ways To Buy Verified Payoneer Accounts In 20245 Brilliant Ways To Buy Verified Payoneer Accounts In 2024
5 Brilliant Ways To Buy Verified Payoneer Accounts In 2024https://localsmmshop.com/
 
Creating an Income Statement with Forecasts: A Simple Guide and Free Excel Te...
Creating an Income Statement with Forecasts: A Simple Guide and Free Excel Te...Creating an Income Statement with Forecasts: A Simple Guide and Free Excel Te...
Creating an Income Statement with Forecasts: A Simple Guide and Free Excel Te...Aurelien Domont, MBA
 
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.daisycvs
 
Your Work Matters to God RestorationChurch.pptx
Your Work Matters to God RestorationChurch.pptxYour Work Matters to God RestorationChurch.pptx
Your Work Matters to God RestorationChurch.pptxOs Hillman
 

Recently uploaded (20)

Top^Clinic ^%[+27785538335__Safe*Women's clinic//Abortion Pills In Harare
Top^Clinic ^%[+27785538335__Safe*Women's clinic//Abortion Pills In HarareTop^Clinic ^%[+27785538335__Safe*Women's clinic//Abortion Pills In Harare
Top^Clinic ^%[+27785538335__Safe*Women's clinic//Abortion Pills In Harare
 
How to refresh to be fit for the future world
How to refresh to be fit for the future worldHow to refresh to be fit for the future world
How to refresh to be fit for the future world
 
The Risks of Ignoring Bookkeeping in Your Business
The Risks of Ignoring Bookkeeping in Your BusinessThe Risks of Ignoring Bookkeeping in Your Business
The Risks of Ignoring Bookkeeping in Your Business
 
Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...
Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...
Pay after result spell caster (,$+27834335081)@ bring back lost lover same da...
 
Global Internal Audit Standards 2024.pdf
Global Internal Audit Standards 2024.pdfGlobal Internal Audit Standards 2024.pdf
Global Internal Audit Standards 2024.pdf
 
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg PfizerJual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
Jual Obat Aborsi Di Sibolga wa 0851/7541/5434 Cytotec Misoprostol 200mcg Pfizer
 
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODFRATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
RATINGS OF EACH VIDEO FOR UNI PROJECT IWDSFODF
 
NFS- Operations Presentation - Recurrent
NFS- Operations Presentation - RecurrentNFS- Operations Presentation - Recurrent
NFS- Operations Presentation - Recurrent
 
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by AccionSeries A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
 
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.docGuide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
Guide to Networking Essentials 8th Edition by Greg Tomsho solution manual.doc
 
MichaelStarkes_UncutGemsProjectSummary.pdf
MichaelStarkes_UncutGemsProjectSummary.pdfMichaelStarkes_UncutGemsProjectSummary.pdf
MichaelStarkes_UncutGemsProjectSummary.pdf
 
zidauu _business communication.pptx /pdf
zidauu _business  communication.pptx /pdfzidauu _business  communication.pptx /pdf
zidauu _business communication.pptx /pdf
 
HAL Financial Performance Analysis and Future Prospects
HAL Financial Performance Analysis and Future ProspectsHAL Financial Performance Analysis and Future Prospects
HAL Financial Performance Analysis and Future Prospects
 
Hyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings releaseHyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings release
 
hyundai capital 2023 consolidated financial statements
hyundai capital 2023 consolidated financial statementshyundai capital 2023 consolidated financial statements
hyundai capital 2023 consolidated financial statements
 
Exploring-Pipe-Flanges-Applications-Types-and-Benefits.pptx
Exploring-Pipe-Flanges-Applications-Types-and-Benefits.pptxExploring-Pipe-Flanges-Applications-Types-and-Benefits.pptx
Exploring-Pipe-Flanges-Applications-Types-and-Benefits.pptx
 
5 Brilliant Ways To Buy Verified Payoneer Accounts In 2024
5 Brilliant Ways To Buy Verified Payoneer Accounts In 20245 Brilliant Ways To Buy Verified Payoneer Accounts In 2024
5 Brilliant Ways To Buy Verified Payoneer Accounts In 2024
 
Creating an Income Statement with Forecasts: A Simple Guide and Free Excel Te...
Creating an Income Statement with Forecasts: A Simple Guide and Free Excel Te...Creating an Income Statement with Forecasts: A Simple Guide and Free Excel Te...
Creating an Income Statement with Forecasts: A Simple Guide and Free Excel Te...
 
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
Abortion pills in Muscut<Oman(+27737758557) Cytotec available.inn Kuwait City.
 
Your Work Matters to God RestorationChurch.pptx
Your Work Matters to God RestorationChurch.pptxYour Work Matters to God RestorationChurch.pptx
Your Work Matters to God RestorationChurch.pptx
 

SCA interim report Q2 2012

  • 1. Interim Report 1 January – 30 June 2012
  • 2. Q2 2012 Macro update  Global economy and private consumption to slow in 2012  Debt crisis in parts of Western Europe has a negative impact  Emerging markets shows relatively good growth  Hygiene products  Good growth in Emerging markets  Low or no growth in Western Europe and North America  Forest products  Lower European demand and unacceptably low prices in publication paper  Continued weak demand and unsatisfactory low prices in solid-wood products  Price increases for Kraftliner during Q2 2 Interim Report Q2 2012
  • 3. Q2 2012 Closed five important deals  Acquisition of Georgia-Pacific’s European tissue operations  Acquisition of Everbeauty an Asian hygiene products company  Increased shareholding in Vinda  Acquisition of PISA in Chile  Divestment of the Packaging business, excluding the two kraftliner mills 3 Interim Report Q2 2012
  • 4. Summary Q2 2012 vs Q2 2011  Sales increased 2%*  Hygiene business  Higher volumes  Higher prices  Good growth in emerging markets • Personal Care, 20%** • Tissue, 17%**  Forest Products  Lower volumes  Lower prices  EBIT increased 16%***  Higher volumes  Lower raw material and energy costs * Excluding exchange rate movements and divestment ** Excluding exchange rate movements *** Excluding items affecting comparability , exchange rate movements and divestments 4 Interim Report Q2 2012
  • 5. Q2 2012 results SEK millions Q2 Q2 Change, Change, unless otherwise stated 2012 2011 % %** Net sales 20,273 20,415 -1 2 EBIT* 2,105 1,810 16 16 EBIT margin* (%) 10.4 8.9 Profit before tax* 1,789 1,527 17 Earnings per share (SEK) 1.85 1.96 Operating cash flow 2,391 1,868 Debt/Equity ratio 0.41 0.55 * Excluding items affecting comparability ** Excluding exchange rate movements, and divestments 5 Interim Report Q2 2012
  • 6. Q2 2012 vs. Q1 2012 Summary  Group  Sales increased 4%  EBIT increased 15%*  Business areas  Personal Care, EBIT increased 17%* • Higher volumes • Improved product mix  Tissue, EBIT increased 10%* • Higher volumes • Lower energy costs • Higher raw material costs  Forest Products, EBIT increased 31%* • Higher prices • Lower volumes • Lower raw material and energy costs * Excluding items affecting comparability 6 Interim Report Q2 2012
  • 7. Personal Care Q2 2012 vs. Q2 2011 6,530  Sales increased 7% (+10%*) 6,116  Incontinence care increased 9%* 7%  Baby diapers increased 14%*  Feminine care increased 8%*  Emerging markets increased 20%** SALES SEKm Q212 Q211 781  EBIT increased 34%*** (41%****) 34%*** 582  Higher volumes  Improved product mix  Cost savings  Lower raw material costs EBIT*** SEKm Q212 Q211 EBIT margin*** 12.0% 9.5% * Excluding exchange rate movements and divestments ** Excluding exchange rate movements *** Excluding items affecting comparability **** Excluding items affecting comparability, exchange rate movements and divestments 7 Interim Report Q2 2012
  • 8. Tissue Q2 2012 vs. Q2 2011 9,461 9,609  Sales decreased 2% (+4%*)  Consumer tissue increased 5%* -2%  AFH tissue increased 2%*  Emerging markets increased 17%**  EBIT increased by 53%*** (45%****) SALES SEKm Q212 Q211  Higher prices 1,021  Improved product mix  Lower raw material costs 53% 668  Cost savings EBIT*** SEKm Q212 Q211 EBIT margin*** 10.8% 7.0% * Excluding exchange rate movements and divestments ** Excluding exchange rate movements *** Excluding items affecting comparability **** Excluding items affecting comparability and exchange rate movements 8 Interim Report Q2 2012
  • 9. Forest Products Q2 2012 vs. Q2 2011  Sales decreased 9% 4,868 5,322  Publication papers, decreased sales • Lower volumes -9%  Solid-wood products, flat sales • Higher volumes • Lower prices SALES SEKm Q212 Q211  Kraftliner, decreased sales • Lower prices • Higher volumes 659  Pulp, decreased sales 433 • Lower prices and volumes -34%*  EBIT decreased 34%* EBIT* SEKm Q212 Q211  Lower prices EBIT margin* 8.9% 12.4%  Higher raw material costs * Excluding items affecting comparability 9 Interim Report Q2 2012
  • 10. Q&A 10 Interim Report Q2 2012